What if CFDA is not granted?, page-16

The WHA ann dated 15 Jan relates to calendar year. Call the company if you want.

Im quite neutral of WHA but by-golly its expensive sp.
The risk to reward does not at all add up.

You know its expensive when brokers do peer comparisions using WHA to reflect how cheap their other company is.

On the subject of names, you would think a long term holder would have easily recognised the launch and rational for having GoldCare as a brand name under the WattleHealth Aust parent company / corp name.
You posters are not watching close enough. Your directors are doing ok, although abit more CR (extra cash holding) would had been better imo.
BTW my true recommendation / sentiment is sell